With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.

Indian generic drugmakers launch a price war against Novo Nordisk’s GLP-1 brands, Ozempic and WeGovy.

Replacing traditional weight management methods with GLP-1 medications can be effective for some, but it's essential to ...

Semaglutide is not just a glucose-lowering drug -- it improves weight and has proven cardiovascular, liver, and renal benefits. ​​Wider availability could therefore help reduce long-term complications ...

As blockbuster weight-loss drugs enter India, experts question pharma marketing, ethics, misuse risks and public health priorities.

A deluge of weight-loss drugs is set to transform the global fight against obesity as India prepares to unleash low-cost ...

Until recently, Indians had few safe ways of joining the global craze for weight-loss drugs. Some smuggled them into the country when returning home from abroad; others chanced it with bootlegged ...

Weight-loss therapy costs are set to reduce substantially by up to 90%, with generic versions of injectable semaglutide are ...

India's Drugs Controller, in collaboration with State Regulators, has initiated a series of targeted actions to curb possible ...

'Weight loss drugs serious medicines for serious problem, shouldn't be used recklessly,' warns AIIMS expert ...

Discover a practical 7-day Indian diet plan designed to help reduce belly fat by focusing on whole foods, spices, and natural ...

On any given morning in Mumbai’s Shivaji Park, power-walkers circle the running track, fitness watches buzzing with every step. Minutes later, some drift toward nearby food stalls, where oil sizzles ...